Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Online

09 may 2017 12:00 p.m. - 11 may 2017 2:00 p.m.

Oversight of Clinical Monitoring: Trends and Strategies

Part 2:The Details of Site Monitoring

Session Chair(s)

Lynn  King, MHA

Lynn King, MHA

Chief Operating Officer

M3 Wake Research, Inc, United States

Part 2:
The Details of Site Monitoring

•Define ICH and FDA requirements for site monitoring
•Regulatory requirements for transferring contractual obligations
•Identify Sponsor responsibilities for oversight
•Introduce “Quality Oversight” programs
•Approaches to monitoring – Centralized and On-Site
•Metrics Champion Consortium – RBM Survey
•Audit/inspection observations and findings regarding site monitoring

Questions/Answers

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.